Comment on Gao et al’s “A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis”

Journal of the American Academy of Dermatology · Elsevier

Аннотация

Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Dina Ghanim, Michael Ghebrial, Chiara Tognaccini, Leah E. Thomas, Zahra Ansari, Khushi Gupta, Jashin J. Wu

Читать у издателя →

Похожие статьи